US 10138482
Compositions for modulating C9ORF72 expression
granted A61PA61P21/00A61P21/02
Quick answer
US patent 10138482 (Compositions for modulating C9ORF72 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P21/00, A61P21/02, A61P25/00, A61P25/02